You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 44 No. 8, August 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit

S. DeSilva, D. B. Drachman, D. Mellits and R. W. Kuncl

We report the long-term results of a therapeutic trial of prednisone in the treatment of Duchenne muscular dystrophy, comparing the age at which 16 treated patients and 38 controls lost the ability to ambulate. Survival curve analysis and group mean comparisons indicate that ambulation was significantly prolonged, by approximately two years, in the prednisone-treated group compared with the control group. The results of this study indicate that prednisone therapy has a long-term beneficial effect in the treatment of Duchenne muscular dystrophy, in addition to the short-term palliation we previously reported. Further studies are needed to establish optimal treatment schedules using prednisone and to develop improved therapeutic agents.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy
King et al.
Neurology 2007;68:1607-1613.
ABSTRACT | FULL TEXT  

The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy
Bonifati et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:1177-1179.
ABSTRACT | FULL TEXT  

Steroid Treatment for Cardiac Function in Duchenne Muscular Dystrophy
Danford
AAP Grand Rounds 2006;15:58-59.
FULL TEXT  

The Muscular Dystrophies: From Genes to Therapies
Lovering et al.
ptjournal 2005;85:1372-1388.
ABSTRACT | FULL TEXT  

Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies
Chakkalakal et al.
FASEB J. 2005;19:880-891.
ABSTRACT | FULL TEXT  

Practice Parameter: Corticosteroid treatment of Duchenne dystrophy: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Moxley et al.
Neurology 2005;64:13-20.
ABSTRACT | FULL TEXT  

Respiratory Care of the Patient with Duchenne Muscular Dystrophy: ATS Consensus Statement
Am. J. Respir. Crit. Care Med. 2004;170:456-465.
FULL TEXT  

Vertebral Fractures in Boys with Duchenne Muscular Dystrophy
Bothwell et al.
CLIN PEDIATR 2003;42:353-356.
ABSTRACT  

Corticosteroids in Duchenne Muscular Dystrophy: A Reappraisal
Wong and Christopher
J Child Neurol 2002;17:183-190.
ABSTRACT  

Prednisone Therapy in Becker's Muscular Dystrophy
Johnsen and Clinic
J Child Neurol 2001;16:870-871.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.